Treatment with human analog (GlyA21, ArgB31, ArgB32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type 1 diabetes [6]

Diabetes Care

Volumn 24, Issue 2, 2001, Pages 411-412

  Moriyama, Hiroaki ^a   Nagata, Masao ^a,b   Fujihira, Kazuhiro ^a   Yamada, Katumi ^a   Chowdhury, Shahead Ali ^a   Chakrabarty, Sagarika ^a   Jin, Zhenzi ^a   Yasuda, Hisafumi ^a   Ueda, Hiroo ^a   Yokono, Koichi ^a  

^a KOBE UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN GLARGINE; INSULIN ZINC SUSPENSION;

ADULT; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG HYPERSENSITIVITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MALE; PRICK TEST; SKIN TEST; TREATMENT OUTCOME;

EID: 0035144194     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.2.411     Document Type: Letter

References (2)

1. Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes
2. Determinant spreading of T helper cell 2 (Th2) response to pancreatic islet autoantigens